Connect with us

Hi, what are you looking for?

Economy

Government in talks with Indian drug maker for Covovax orders

THE PHILIPPINE government and Serum Institute of India Ptv. Ltd. are in talks for the supply of 30 million doses of coronavirus vaccine Covovax.

The vaccine, which is in the third phase of clinical trials, could become available in the third quarter of next year, once a supply agreement is reached, the Indian drug maker said in a statement on Sunday.

“If and when the negotiations are concluded successfully, this would be a wonderful development for us Filipinos,” Luningning Villa, medical director at Faberco Life Sciences, said in the statement.

Faberco is the local partner of Serum Institute, which is manufacturing Covovax for US biotechnology company Novavax, Inc. with which it developed the vaccine.

Ms. Villa, who met with vaccine czar Carlito G. Galvez, Jr last week, said she expects the talks to be completed by year-end.

About 15,000 patients have participated in phase three trials of Covovax in the United Kingdom and 30,000 in the US and Mexico.

Initial phases of the clinical trials were conducted in Australia, South Africa and India.

The Serum Institute last month authorized Faberco, a distributor of specialized healthcare products, to represent the Philippines for the supply of the coronavirus vaccine.

Faberco has partnered with the Indian drug maker for key vaccine programs such as inactivated polio, rotavirus, pneumococcal conjugate and COVID-19 vaccines.

Ms. Villa told BusinessWorld last month Covovax was expected to be “logistically manageable” in terms of cold chain requirements because it does not require deep freezing during storage and transport.

The government plans to immunize 20 million Filipinos yearly in the next three years.

The private sector, the government, and UK-based drug maker AstraZeneca Plc have signed a deal for the purchase of 2.6 million doses of vaccines, expected to arrive in as early as May.

The Department of Health (DoH) reported 1,754 coronavirus infections on Sunday, bringing the total to 459,789.

The death toll rose to 8,947 after 36 more patients died, while recoveries increased by 8,080 to 429,134, it said in a bulletin.

There were 21,708 active cases, 81.3% of which were mild, 8.7% did not show symptoms, 6.4% were critical, 3.2% were severe and 0.37% were moderate.

Quezon City reported the highest number of new cases at 163, followed by Rizal province at 104, Benguet and Laguna at 83 each and Bulacan at 61.

DoH said nine duplicates had been removed from the tally, while 25 recovered cases were reclassified as deaths. Twelve laboratories failed to submit their data on Dec. 19.

The coronavirus has sickened about 76.6 million and killed 1.7 million people globally, according to the Worldometers website, citing various sources including data from the World Health Organization (WHO).

About 53.8 million people have recovered, it said. — Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Economy

Global crude oil prices have surged in recent weeks, as more economies reopened and demand increased. — PHILIPPINE STAR/ MICHAEL VARCAS By Luz Wendy...

Economy

Philippine President Rodrigo R. Duterte and Chinese President Xi Jinping attend a signing ceremony held in Beijing, China, Oct. 20, 2016. — REUTERS/NG HAN...

Economy

The government has allowed cinemas to reopen with limited capacity after Metro Manila was placed under Alert Level 3. — PHILIPPINE STAR/ MICHAEL VARCAS...

Economy

By Keren Concepcion G. Valmonte, Reporter SHARE buyback programs enable listed companies to maximize key opportunities to secure better business prospects and stabilize shareholders’...

Economy

By Arjay L. Balinbin, Senior Reporter NLEX Corp., operator of North Luzon Expressway (NLEX) and Subic Clark Tarlac Expressway (SCTEX), expects higher traffic volume...

Economy

1 of 4 The all-new Nissan Almera boasts a sleek yet spacious design that’s vastly more compelling than the homely styling of its predecessor’s....

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

Pfizer Inc on Wednesday raised its 2021 sales forecast for its COVID-19 vaccine by 29% to $33.5 billion, and said it believes people will...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!